All GLG News Analyses Filed Under: Business of Medicine

Generic Losartan Will Probably Not Make Huge Impact in Malaysia

August 6, 2009

Analysis by:GLG Expert Contributor

Analysis of:  Ranbaxy launches generic Losartan in Malaysia | www.pharmabiz.com

The advent of generic Losartan is going to provide a cheaper version of an effective antihypertensive drug for Malayan doctors and patients. The benefits will not only result from savings compared to brand name Losartan but also from savings compared to other similar compounds like Valsartan, Irbesartan...

Will The Medical Device Safety Act of 2009 Ultimately Benefit Patients?

August 6, 2009

Analysis by:GLG Expert Contributor

Analysis of:  Senate HELP Committee Hearing on Defective Medical Devices | www.c-span.org

The Senate Health, Education, Labor and Pensions (HELP) Committee started hearings on medical device safety yesterday, in an effort to pave the way for the Medical Device Safety Act of 2009. Proponents argue that manufacturers should not be shielded from liability and that patients should have thelegal...

Treatment of Social Anxiety Disorderved

August 6, 2009

Analysis by:GLG Expert Contributor

Analysis of:  NeuroSearch successfully advances NSD-721 for treatment of social anxiety disorder and receives EUR 5 million in equity financing under the alliance with GlaxoSmithKline | www.pipelinereview.com

 NeuroSearch new drug NSD-721 will be of great benefit to patients with Social Anxiety Disorder.

RPG Gearing up for Biosimilars Battle post Patent expiry!!!

August 4, 2009

Analysis by:GLG Expert Contributor

Analysis of:  RPG Life Sciences launches its 5th biotech product, Sirolimus | www.business-standard.com

RPG Life sciences is a small player campared to other heavy weights in Indian pharma sector. They are making progress slowly but surely. Sirolimus will give them entry into this niche segment of Immunisuppressants which has little competition from the generic players currently. Having a plant approved...

Is this the end of Bifeprunoxyndrome.

August 3, 2009

Analysis by:GLG Expert Contributor

Analysis of:  Lundbeck, Solvay discontinue all joint R&D activities for bifeprunox to treat schizophrenia | www.pharmabiz.com

 Bifeprunox initially looked like it might be a blockbuster for Solvoy when it was first studied.

Indian Pharma to set to hit $ 70 Bn Jackpot

August 3, 2009

Analysis by:GLG Expert Contributor

Analysis of:  $70 bn worth drugs to go off-patent, benefiting India: Report- Pharmaceuticals-Healthcare / Biotech-News By Industry-News-The Economic Times | economictimes.indiatimes.com

Patented molecules with Market sales worth 70 Bn are set to go off patent in the next  3 years. Indian companies are already gearing up for this avalanche from now. Most have them have invested heavily in RnD have started CRAMs operations, are working on API development for these products. Its going...

Physician Owned Hospitals Must Compete on Level Playing Field

August 2, 2009

Analysis by:GLG Expert Contributor

Analysis of:  House Health Bill Would Ban New Physician-Owned Hospitals | blogs.wsj.com

If the current pending legislation does not ban the physician owned hospital, the legislation should at minimum ensure that these hospitals are forced to compete on a level playing field. This would include requiring them to provide Emergency Services and services needed by the community other than...

Scaring the Public with Health Care Reform

July 30, 2009

Analysis by:GLG Expert Contributor

Analysis of:  The Healthcare Bankruptcy Myth | www.realclearmarkets.com

In order to pass health care, proponents are misleading the public with scary, untruthful data. A recent study by Dr. David Himmelstein asserts that the share of bankruptcies attributable to health care costs rose by 50%between 2001 and 2007. But the study contradicts the economics literature. Most...

What's in it for ME?

July 30, 2009

Analysis by:GLG Expert Contributor

Analysis of:  OMB Director Questions Insurance Giant's Approach to Reform | www.washingtonpost.com

All parties to reform continue to look out for their own interests, at the expense of the global picture.

Could Health Insurers be Part of the Cost Containment Solution After All?

July 30, 2009

Analysis by:GLG Expert Contributor

Analysis of:  OMB Director Questions Insurance Giant's Approach to Reform | www.washingtonpost.com

Everybody and his brother has been beating up on the health insurance industry as one of the major causes of the cost explosion. Much of that can be justified in fact when comparing the administrative costs of our predominantly private insurance system relative to those of other countries' where public...

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next71 to 80 of 1030